Cargando…
A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection
Therapeutic agents to the central nervous system (CNS) need to be efficiently delivered to the target site of action at appropriate therapeutic levels. However, a limited number of effective drugs for the treatment of neurological diseases has been developed thus far. Further, the pharmacological me...
Autores principales: | Kanno, Takuya, Yasutake, Kaori, Tanaka, Kazunori, Hadano, Shinji, Ikeda, Joh-E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633190/ https://www.ncbi.nlm.nih.gov/pubmed/29016670 http://dx.doi.org/10.1371/journal.pone.0186227 |
Ejemplares similares
-
Alpha-2 HS glycoprotein in the hypercalcaemia of multiple myeloma.
por: Crawford, S. M.
Publicado: (1984) -
A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model
por: Tanaka, Kazunori, et al.
Publicado: (2014) -
Decreased expression of alpha-2-HS glycoprotein in the sera of rats treated with Eurycoma longifolia extract
por: Chen, Yeng, et al.
Publicado: (2015) -
Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia
por: Dong, Beibei, et al.
Publicado: (2013) -
Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer
por: Fan, Nai-Jun, et al.
Publicado: (2014)